Anita Goel
Dr. Anita Goel, MD Ph.D is a Harvard-MIT-Stanford trained Physicist, Physician, and pioneering scientist and visionary in the emerging field of Nanobiophysics - a new science at the convergence of physics, nanotechnology, and biomedicine Harvard Frontiers of Science. At the Nanobiosym Research Institute (NBS) Nanobiosym R&D Institute Website, Dr. Goel examines the physics of one of the most fundamental processes of living systems: the way nanomotors read and write information into DNA. She and her team are commercializing these innovations to empower people with real-time precision data and insights about their health. Named as one  of the World’s “Top 35 science and technology innovators” by MIT Technology Review and one of the "World's Most Influential Visionaries in Biotech" by Scientific American Top 100 Biotech Visionaries by Scientific American, Dr. Goel has been recognized globally by prestigious honors including three DARPA Breakthrough Awards, two USAID Grand Challenge Awards , NASA's Galactic Challenge Award (with Elon Musk's SpaceX) , and multiple awards from DOD, DOE, AFOSR, and NSF. Dr. Goel has over 70 patents worldwide and has published in leading scientific journals including Nature Nanotechnology and Scientific American and PNAS . She has testified in the  US Senate for the $1.5 Billion dollar National Nanotechnology Initiative ; advised President Obama’s PCAST for his Strategy for American Innovation; served on the Triennial Review Board of the National Academy of Sciences ; on the Committee on Manufacturing Innovation of the National Academy of Engineering; on the Canadian Institute for Advanced Research (CIFAR). She served on the Nanotechnology & Scientific Advisory Boards of Lockheed Martin and PepsiCo Corporations . As the Chairman and CEO of Nanobiosym Diagnostics (NBSDx), Dr. Goel oversees product design, engineering, clinical trials, regulatory approvals and manufacturing of the company's breakthrough technologies, such as the X-PRIZE  winning Gene-RADAR® and its “apps” for personalized precision medicine, digital health and global health security. In 2020, Barclay’s Bank and the Unreasonable Group selected Nanobiosym Dx amongst the “World’s Top 10 Companies solving the Global COVID Crisis” and Scientific American featured her work on how mobile precision testing for COVID could safely re-open the US and Global Economy. Dr. Goel holds a Ph.D. and M.A. in Physics from Harvard University, an MD from the Harvard-MIT Joint Division of Health Sciences and Technology (HST) at Harvard Medical School and a BS in Physics with Honors  & Distinction from Stanford University. Education. Goel received a PhD in physics from Harvard University, where she was mentored by Nobel laureate Dudley R. Herschbach. Her thesis was entitled "Single Molecule Dynamics of Motor Enzymes Along DNA". She received a BS in physics with honors and distinction from Stanford University, where her mentor was Nobel laureate Steven Chu. She also holds an M.D. from the Harvard–MIT Joint Division of Health Sciences and Technology (HST).